LQDA

NASDAQ · Pharmaceuticals

Liquidia Corp

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$90.22

+0.80 (+0.89%)

As of Aug 8, 9:56 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 12 80%

Hold 3 20%

Sell 0 0%

Price Target

Analyst Price Target -52.2% upside

Low Target $30.71

Average Target $43.17

High Target $51.56

Current Price $90.22

Current
$90.22

Target
$43.17

$30.71 $43.17 avg $51.56

Scenario Analysis

Bear Case

$30.71

-66.0%

Low target

Base Case

$43.17

-52.2%

Avg target

Bull Case

$51.56

+-42.9%

High target

Risk/Reward

0.6x

Unfavorable

Price in Context

52-Week High

$91.57

-1.5% from high

52-Week Low

$19.02

+374.3% from low

50-Day SMA

$37.31

+141.8% vs SMA

200-Day SMA

$25.48

+254.1% vs SMA

RSI (14)

31.7

Neutral

Target vs 52W High

$43.17

-52.9% vs high

Next Earnings Report

Aug 12, 2026 · Before Market Open

until earnings

EPS Est: $0.76

Earnings in 2 days. Analyst targets may shift significantly after the report.

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+15.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.9%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+26.7%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+169.6%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.1%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+188.8%